FDA Recall Terminated

Habib EUS RFA, 20mm electrode active tip, Material Number/UPN: 6700 - Product Usage: The Habib EUS RFA is indicated for coagulation and ablation of soft tissue when used in conjunction with compatible radiofrequency generator.

Recall: Z-0668-2020 · Initiated November 18, 2019

Recall

Recall Number
Z-0668-2020
Event Number
84375
Firm
Boston Scientific Corporation
FEI Number
3005099803
Product Code
JOS
Status
Terminated
Root Cause
Device Design
Initiated
November 18, 2019
Terminated
June 25, 2020
Address
300 Boston Scientific Way, Marlborough, MA, 01752-1291

Description

Habib EUS RFA, 20mm electrode active tip, Material Number/UPN: 6700 - Product Usage: The Habib EUS RFA is indicated for coagulation and ablation of soft tissue when used in conjunction with compatible radiofrequency generator.

Reason

During testing on the Habib EUS RFA device, a temperature increase was observed at the tip of the EUS-FNA needle. It was determined that capacitive 5 coupling presents a risk of energy transfer from the Habib EUS RFA active tip to the introducer device. This capacitive coupling could result in thermal injury to tissue outside of the targeted treatment area due to its use with an un-insulated EUS-FNA needle requiring little or no medical intervention.

Action

On November 18, 2019 the firm distributed Urgent Medical Device Recall Communication letters by mail stating: Urgent Medical Device Recall - Immediate Action Required HABIB" EUS RFA 6500 and 6700 Dear Materials Manager / Field Action Contact: Boston Scientific (BSC) is initiating a voluntary removal of all HABIB" EUS RFA devices that remain in distribution. BSC acquired EMcision in March 2018. EMcision was the manufacturer of the Habib EUS RFA devices subject to this recall. The EMcision UK entity is no longer operating, therefore BSC is initiating the action. BSC recently identified that these devices present a risk of energy transferring from the active tip to the introducer device which may result in thermal injury to tissue outside the intended treatment area. The most common injury anticipated is tissue damage requiring little or no medical intervention. There is a remote probability of tissue damage or perforation occurring as a result of this issue that may require medical intervention, however this has not been reported to date. There is no additional follow up recommended for patients treated with these devices beyond normal standard of care. This recall affects all UPNs and batches listed below. No other products or UPNs are impacted by this notification. Refer to the Reply Verification Form included with this notification package for the list of individual batches we have record of shipping to your facility. Use and distribution of any remaining unused product affected by this removal should cease immediately. UPN: 6500 GTIN: 5060271140725 Batches: 17-C02, 17-C06, 17-C07, 17-C08 UPN: 6700 GTIN: 5060271140596 Batches: 17-C01, 17-C03, 17-C04, 17-C05, 17-C09 If you identify any affected product within your inventory, please segregate the product immediately and return it to Boston Scientific in accordance with the enclosed instructions. If you are a distributor, please note that this removal is to the customer level. Please notify any

Distribution

Worldwide distribution - US Nationwide distribution in the states of AL, AZ, CA, CO, CT, FL, NJ, NY, MA, MD, MN, TN, TX and countries of Canada, India, Australia, Great Britain, Greece, Spain.

Quantity

179